Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 16, 1997

View Archived Issues

Millennium issued U.S. patent for human melanoma gene

Vanguard Medica: HY 1997 highlights

Ibex Technologies: FY 1997 highlights

Jenner Technologies initiates clinical testing of AdjuVax-100a

Genetronics evaluates its electroporation therapy in phase II

Preclinical cholesterol-lowering efficacy described for FR-194738

Dose-dependent pain relief with Quadramet in breast and prostate cancer patients

Lipogelosomes: a novel approach to lowering cholesterol

HIV-infected T-cells and macrophages efficiently killed by new T-cell gene therapy

Niaspan clinical activity reported at atherosclerosis symposium

Camptothecin derivatives with potent antitumor activity prepared at P&U

Clinical activity of policosanol reported

Ortho describes bacterial HPK inhibitors as antibacterial agents

Schering AG discloses improved taxanes

Novel protein tyrosine kinase inhibitors particularly useful for osteoporosis

Potent alpha2-adrenoceptor blockers prepared by Pierre Fabre

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

New bronchodilators from Nippon Suisan

Fujisawa describes bradykinin agonists with wide therapeutic application

PMA supplement submitted for Digene's HPV diagnostic

Takeda's Blopress approved in EC

Nycomed licenses new anthracycline from Anthra

UroCor to copromote Zeneca urology products

Promising preclinical data for Inex's gene delivery system

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

S-1: pharmacokinetics of components in rats after single and multiple oral doses

Do calcium channel blockers increase risk of cancer?

Integra Artificial Skin receives approval in Taiwan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...